American Cancer Society urges COVID-19 booster efforts among immunocompromised patients
HIV and cancer patients, organ transplant recipients and those taking immunosuppressant drugs comprise 3% of US population
{{#rendered}} {{/rendered}}
Ahead of an anticipated FDA authorization for COVID-19 booster vaccines among certain individuals with weakened immune systems, the American Cancer Society has voiced full support behind efforts to offer cancer patients greater protection against COVID-19.
CLICK HERE TO FIND A COVID-19 VACCINE NEAR YOU
HIV and cancer patients, organ transplant recipients and those taking immunosuppressant drugs comprise about 2.7% of the U.S. adult population, and growing evidence has indicated the population doesn’t respond as well to COVID-19 vaccines, inducing lower levels of protective antibodies. Emerging data suggests an additional dose could boost the antibody response.
{{#rendered}} {{/rendered}}
"As an organization dedicated to improving the lives of cancer patients and their families, the American Cancer Society strongly supports efforts to protect and improve the health and well-being of our community," Dr. Karen E. Knudsen, CEO of the American Cancer Society and American Cancer Society Cancer Action Network, told Fox News.
PFIZER COVID-19 VACCINE JUST 42% EFFECTIVE AGAINST INFECTION AMID DELTA SPREAD, PREPRINT SUGGESTS
"The American Cancer Society urges further investigation as per whether booster vaccinations may improve COVID-19 protection amongst the immunocompromised population," the statement continues in part.
{{#rendered}} {{/rendered}}
CLICK HERE FOR FULL CORONAVIRUS COVERAGE
ACS urged all those eligible for COVID-19 vaccinations to roll their sleeves and receive a vaccine, including cancer patients in consultation with a health care provider.
It is not immediately clear which immunocompromised patients will become eligible for a third dose, however reports have noted solid organ transplant recipients and patients with similar compromised immune systems could fall under the expanded authorization.